vCJD and CJD by the Numbers

As of Dec. 1, 2003, 153 cases of variant Creutzfeldt-Jakob disease (vCJD) were reported: 143 in the United Kingdom, 6 in France, and 1 each in Italy, Canada, Ireland, and the United States. Nearly all of the affected people had been in the UK between 1980 and 1996, during a large bovine spongiform encephalopathy outbreak.Between 1997 and 2003, 731 cases of CJD – sporadic, familial and iatrogenic – were reported in the United States. The rate of deaths due to this type of CJD has rema

Written byChristine Bahls
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

As of Dec. 1, 2003, 153 cases of variant Creutzfeldt-Jakob disease (vCJD) were reported: 143 in the United Kingdom, 6 in France, and 1 each in Italy, Canada, Ireland, and the United States. Nearly all of the affected people had been in the UK between 1980 and 1996, during a large bovine spongiform encephalopathy outbreak.

Between 1997 and 2003, 731 cases of CJD – sporadic, familial and iatrogenic – were reported in the United States. The rate of deaths due to this type of CJD has remained relatively constant, according to the Centers for Disease Control and Prevention. In the United Kingdom, 827 cases were reported between 1990 and April 2004.

Sources: Centers for Disease Control and Prevention, UK Department of Health, National Prion Disease Pathology Surveillance Center

- Christine Bahls

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies